Understanding the evidence used in drug product withdrawals
European Pharmaceutical Review
DECEMBER 14, 2023
They enable a range of observational study designs to be used where researchers study a period of exposure to a particular medicine and compare it with a control period of non-exposure in the same patient to establish any changes in the risk of adverse side effects. 2018; 8(1). EMA/95098/2010. Internet] European Medicines Agency.
Let's personalize your content